COCH Earnings Date: Nov 5, 2026 (Estimated) — Envoy Medical, Inc.
NASDAQ · Healthcare · Medical Devices
Updated
When is COCH's next earnings date?
Envoy Medical, Inc. (COCH) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.70 on revenue of $85,000.
How did COCH do in its last earnings report?
In its most recent report on Aug 10, 2026 (Q2 2026), Envoy Medical, Inc. posted EPS of -$0.70 versus the -$0.80 estimate, a beat of 12.5%. Revenue was $51,000 against a $50,000 estimate. The stock's 1-day post-earnings move was +5.0%.
How much does COCH stock move after earnings?
COCH beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 4.9% (up or down) in the day after earnings.
About Envoy Medical, Inc.
Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. Established in 1995, the company originally operated as St. Croix Medical, Inc. before officially rebranding to Envoy Medical, Inc. in December 2004. Envoy Medical, Inc. is headquartered in White Bear Lake, Minnesota.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 | Q2 2026 | -0.80 | -0.70 | +12.50% | $51,000 | ✅ Beat | +5.04% | +19.19% | +5.94% |
| 2026-05-11 | Q1 2026 | -1.40 | -0.80 | +42.86% | $39,000 | ✅ Beat | -0.23% | +0.23% | -3.95% |
| 2026-03-23 | Q4 2025 | -2.40 | -2.60 | -8.33% | $75,000 | ❌ Miss | -3.37% | -15.95% | -7.91% |
| 2025-11-10 | Q3 2025 | -2.80 | -3.50 | -25.00% | $42,000 | ❌ Miss | -0.34% | -4.91% | +16.98% |
| 2025-07-31 | Q2 2025 | -2.90 | -3.20 | -10.34% | $78,000 | ❌ Miss | -6.22% | -3.01% | -22.28% |
| 2025-03-31 | Q4 2024 | -3.10 | -4.60 | -48.39% | $42,000 | ❌ Miss | -4.41% | +4.41% | +2.94% |
| 2024-11-14 | Q3 2024 | -2.70 | -3.70 | -37.04% | $56,000 | ❌ Miss | +0.47% | +3.29% | -17.37% |
| 2024-08-12 | Q2 2024 | -2.50 | -2.70 | -8.00% | $68,000 | ❌ Miss | +19.47% | +15.49% | +39.82% |
Showing last 8 quarters.